bioavailability of glp-1 treatments Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Medications for Weight Loss:
Description
Jun, H.S
Are There Specific Patient Populations Who Might Benefit Most from GLP-Agonists
doi: 10.1002/iub.2046
People Eating Too Few Calories Strong appetite suppression can sometimes lead people to unintentionally under-eat
The views expressed are those of the author, and do not necessarily reflect the views of Penn Mutual Asset Management
Ask about the titration protocol and what to expect during the first four to six weeks of treatment
